Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €57.27 EUR
Change Today +0.079 / 0.14%
Volume 0.0
As of 7:10 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - alkermes plc (8AK)

Name (Connections)Board RelationshipsTitleKey Developments
Floyd Bloom M.D. 92 RelationshipsCo-Founder, Director and Member of Audit & Risk CommitteeAlkermes Inc. Announces Securities and Exchange Commission Letter Ending Backdating Investigation
05/25/07
Paul Mitchell 6 RelationshipsLead Independent Director, Chairman of Audit & Risk Committee and Member of Compensation CommitteeAlkermes, Inc. announced delayed 10-Q filing
08/10/06
Robert Breyer 6 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Audit & Risk CommitteeAlkermes, Inc. announced delayed annual 10-K filing
05/29/07

Compensation Committee* - alkermes plc (8AK)

Name (Connections)Board RelationshipsTitle
David Anstice 134 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Limited Compensation Sub Committee
Paul Mitchell 6 RelationshipsLead Independent Director, Chairman of Audit & Risk Committee and Member of Compensation Committee
8AK Compensation vs. Industry
810.2K
312.4K
Chief Executive Officer
444.1K
221.1K
Chief Financial Officer
437.5K
277.4K
Chief Operating Officer
Share price activity for ALKERMES PLC (8AK)
52 Week Price Performance
8AK
Industry Average

Nominating Committee* - alkermes plc (8AK)

Name (Connections)Board RelationshipsTitleKey Developments
Robert Breyer 6 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Audit & Risk CommitteeGeraldine Henwood Resigns as Member of Board of Alkermes Public Limited Company
03/9/15

Corporate Governance Committee* - alkermes plc (8AK)

Name (Connections)Board RelationshipsTitle
Robert Breyer 6 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Limited Compensation Sub Committee
8AK and Competitor
Insiders vs. External
Board
29%
71%
Alkermes plc
11%
89%
Pacira Pharmaceuticals, Inc.
25%
75%
Salix Pharmaceuticals Ltd.
25%
75%
Ranbaxy Laboratories Ltd.
9%
91%
Jazz Pharmaceuticals Public Limited Company
16%
84%
Cosmo Pharmaceuticals S.p.A.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8AK:GR €57.27 EUR +0.079

8AK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cosmo Pharmaceuticals SA SFr.164.50 CHF -2.50
Jazz Pharmaceuticals PLC $173.39 USD +0.29
Pacira Pharmaceuticals Inc/DE $91.11 USD +1.19
Ranbaxy Laboratories Ltd 805.20 INR -14.10
Salix Pharmaceuticals Ltd $172.63 USD +0.08
View Industry Companies
 

Industry Analysis

8AK

Industry Average

Valuation 8AK Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 14.8x
Price/Book 6.6x
Price/Cash Flow 329.2x
TEV/Sales 13.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.